Guselkumab, Risankizumab, and Tildrakizumab in the Management of Hidradenitis Suppurativa: A Review of Existing Trials and Real-Life Data by Martora F, Scalvenzi M, Battista T, Fornaro L, Potestio L, Ruggiero A, Megna M

Connect to this object online.

Biologics for the Management of Erythrodermic Psoriasis: An Updated Review by Potestio L, Camela E, Cacciapuoti S, Fornaro L, Ruggiero A, Martora F, Battista T, Megna M

Connect to this object online.

The Role of Teledermatology During the COVID-19 Pandemic: A Narrative Review by Ruggiero A, Martora F, Fabbrocini G, Villani A, Marasca C, Megna M, Fornaro L, Comune R, Potestio L

Connect to this object online.

Efficacy and Safety of Anti-TNF Biosimilars for Psoriasis in Pediatric and Geriatric Populations: A 72-Week Real-Life Study by Megna M, Fornaro L, Potestio L, Luciano MA, Nocerino M, Delfino M, Guarino M, Fabbrocini G, Camela E

Connect to this object online.